Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Malaria Chemoprevention With Monthly Treatment With Dihydroartemisinin-Piperaquine for the Post-discharge Management of Severe Anaemia in Children Less Than 5 Years in Malawi

NCT02721420 is registered in ClinicalTrials.gov with Kamuzu University of Health Sciences as lead sponsor.

NCT NCT02721420
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02721420 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Malaria Chemoprevention With Monthly Treatment With Dihydroartemisinin-Piperaquine for the Post-discharge Management of Severe Anaemia in Children Less Than 5 Years in Malawi
Lead sponsor
Kamuzu University of Health Sciences
Phase
Phase 3
Overall status
Unknown status
Start date
March 24, 2016
Completion date
December 31, 2019
Enrollment
375 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

malaria, severe anemia